Management of implant failure during transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 3, 2010, Pages 440-449

  Ussia, Gian Paolo ^a,b   Barbanti, Marco ^a   Immè, Sebastiano ^a   Scarabelli, Marilena ^a   Mulè, Massimiliano ^a   Cammalleri, Valeria ^a   Aruta, Patrizia ^a   Pistritto, Anna Maria ^a   Capodanno, Davide ^a,b   Deste, Wanda ^a   Di Pasqua, Maria Concetta ^a   Tamburino, Corrado ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Excellence Through Newest Advances ETNA Foundation   (Italy)

Author keywords

Aortic stenosis; Bail out; Percutaneous; Prosthesis

Indexed keywords

ADULT; AGED; AORTA PRESSURE; AORTA STENOSIS; AORTA SURGERY; AORTA VALVE; ARTICLE; ARTIFICIAL EMBOLISM; ASCENDING AORTA; BALLOON DILATATION; BLEEDING; CEREBROVASCULAR ACCIDENT; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART CATHETER; HEART DEATH; HEART INFARCTION; HUMAN; IMPLANT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PROSTHESIS; PROSTHESIS FAILURE; SAFETY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT FAILURE; VALVULOPLASTY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; AORTOGRAPHY; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DEVICE REMOVAL; ECHOCARDIOGRAPHY; FEMALE; FOREIGN-BODY MIGRATION; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77956839815     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22595     Document Type: Article

References (19)

1. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009;53:1829-1836.
2. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: Results of three device generations of the CoreValve® Revalving System. Circ Cardiovasc Intervent 2008;1:167-175.
3. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, Devarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, Delarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-1090.
4. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pièrard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;11:1463-147.
5. Tamburino C, Barbanti M, Capodanno D, Ussia GP. Transcatheter aortic valve implantation: What has been done and what is going to do. Future Cardiol 2010;6:83-95.
6. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, Tuzcu ME, Kodali S, Leon MB, Webb JG. Transcatheter aortic valve implantation: Review of the nature. Management, and avoidance of procedural complications. J Am Coll Cardiol Intv 2009;2:811-820.
7. Tamburino C, Capodanno D, Mulè M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia GP. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009;21:93-98.
8. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-822.
9. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; Society of Thoracic Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003;75:1856-1865.
10. Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, Bonato R, Pittarello D, Isabella G, Iliceto S Ramondo A. Expanding the eligibility for transcatheter aortic valve implantation: The trans-subclavian retrograde approach using the III Generation CoreValve Revalving System. J Am Coll Cardiol Intv 2009;2:828-833.
11. Ussia GP, Mulè M, Tamburino C. The valve-in-valve technique: Transcatheter treatment of aortic bioprosthesis malposition. Catheter Cardiovasc Interv 2009;73:713-716.
12. Ussia GP, Barbanti M, Tamburino C. Consequences of underexpansion of a percutaneous aortic valve bioprosthesis. J Invasive Cardiol 2010;22:161-166.
13. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006;47:1214-1223.
14. Piazza N, Grube E, Gerckens U, Den Heijer P, Linke A Luha O, Ramondo AB, Ussia GP, Wenaweser P, Windecker S, Laborde JC, De Jaegere P, Serruys PW: on the behalf of the clinical centres who actively participated in the registry. Procedural and 30-day outcomes following transcatheter aortic\valve implantation using the third generation (18 Fr) CoreValve ReValving System: Results from the multicentre, expanded\evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
15. Piazza N, Schultz C, de Jaegere P, Serruys PW. Implantation of two self-expanding aortic bioprosthesis valves during the same procedure? Insight into valve-in-valve implantation ('Russian Doll' Concept). Catheter Cardiovasc Interv 2009;73:530-539.
16. Tuzcu ME. Transcatheter aortic valve replacement malposition and embolization: Innovation brings solutions also new challenges. Catheter Cardiovasc Interv 2008;72:579-580.
17. Al Ali AM, Altwegg L, Horlick EM, Feindel C, Thompson CR, Cheung A, Carere RG, Humphries K, Ye J, Masson JB, Webb JG. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv 2008;72:579-580.
18. Gerckens U, Latsios G, Mueller R, Buellesfeld L, John D, Yuecel S, Sauren B, Felderhof T, Iversen S, Gruce E. Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) corevalve prostheses in 1 procedure. J Am Coll Cardiol Interv 2010;3:244-250.
19. Piazza N, Cutlip DE, Onuma Y, Kappetein AP, de Jaegere P, Serruys PW. Clinical endpoints in transcatheter aortic valve implantation: A call to ARC for standardised definitions. EuroIntervention 2009;5:29-31.